in BS Myco Biotech Company Limited from the Sellers is at Baht 50 million after this transaction will result in the BS Myco Biotech being a subsidiary of the Company. 5.2 Payment The Company paid the
. Chiang Jung-Tsung with Ms. Panisara Suratroongrojkul have authority to sign for payment with company stamp. 2.3 Fixed deposit account requires Mrs. Su, Ming - Fen to be a single authorized person to sign
350,000.00 Baht 3. Acknowledged the company’s performance and certified the company balance sheet and financial statement (as at December 31st, 2017). 4. Approved the dividend payment and propose to the Annual
. Acknowledged the company’s performance and certified the company balance sheet and financial statement (as at December 31st, 2017). 4. Approved the dividend payment and propose to the Annual General Meeting of
for LPG customers decreased form the same period of previous year as the Company received payment from those reserved customers during the period. Statement of Financial Position Unit: Million Baht tel
percent of the total shares of NEXT, from the Seller. The Company shall pay for the share acquisition upon a condition that the payment amount is varied according to the calculation from the earnings before
Exchange of Thailand on February 12, 2020. 2. The resolution of The Board of Director No. 3/2020 dated on May 13, 2020 The company received interest payment in amount of 480,821.90 baht already, and still
concrete product business, food business and oil business. 3.3 In 2018, the Company received the payment from trade receivables at the total amount of Baht 329.50 million, which the Company had already
product business and food business. 3.3 During the third quarter of 2018, the Company received the payment from trade receivables at the amount of Baht 270.48 million, which the Company had already
payment from the accounts receivable that the Company has already recognized allowance for doubtful accounts. Baht 13.54 million was deducted from administrative expenses. 3.3 Financial cost for the third